Pharmaceutical

Novartis acquires Mariana in $1.75bn deal to strengthen radioligand portfolio 

Under the terms of the deal, Mariana will receive $1bn and up to $750m in additional milestone payments from Novartis.

May 3, 2024 - 00:00
Novartis acquires Mariana in $1.75bn deal to strengthen radioligand portfolio 
Under the terms of the deal, Mariana will receive $1bn and up to $750m in additional milestone payments from Novartis.
Read the original article

Tags:

Previous Article

Novo Nordisk aims for market domination, boasts $1.5bn obesity sales in Q1

Next Article

Biotechs face upward battle with recruiting patients on obesity trials

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Ocular launches ocular implant trial to combat macular degeneration

Ocular launches ocular implant trial to combat macular ...

Oct 7, 2023

Bayer’s new CEO was dealt a duo of ‘clearing events.’ Tough choices lie ahead

Bayer’s new CEO was dealt a duo of ‘clearing events.’ T...

Nov 21, 2023

Investment surges, hurdles and emerging innovations in neuroscience

Investment surges, hurdles and emerging innovations in ...

Nov 11, 2024